GENE ONLINE|News &
Opinion
Blog

NVX-CoV2373
SK Bioscience Files for Approval of Novavax’s COVID-19 Vaccine
2021-11-17
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
SK Bioscience Receives EU-GMP Certification for COVID-19 Vaccine Production Plant, Making it Korea’s First
2021-05-18
Novavax’s Protein Subunit Vaccine Shows 89.3% Efficacy in Phase 3 UK Trial
2021-01-29
Asia Highlights|July
2020-07-31
Novavax to Deliver 100 Million COVID-19 Vaccine Doses by January 2021
2020-07-12
COVID-19 Vaccine: Novavax Gets Funding from the US Department of Defense
2020-06-09
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top